Diaceutics PLC

DXRX

GB00BJQTGV64

Business Support Services

Delayed London S.E. Other stock markets 09:34:26 23/05/2024 BST			5-day change	1st Jan Change
127.2 ^GBX	-0.24%		+15.64%	+46.21%

05-21	EARNINGS AND TRADING: Topps Tiles in strategic shift as swings to loss	AN
05-21	Transcript : Diaceutics PLC, 2023 Earnings Call, May 21, 2024

Diaceutics PLC Provides Earnings Guidance for the Year Ended 31 December 2019

January 13, 2020 at 07:00 am

Diaceutics PLC provided earnings guidance for the year ended 31 December 2019. The Group's revenue for the year to 31 December 2019 are expected to be approximately £13.4 million (2018: £10.4 million).

Latest news about Diaceutics PLC

EARNINGS AND TRADING: Topps Tiles in strategic shift as swings to loss	05-21	AN
Transcript : Diaceutics PLC, 2023 Earnings Call, May 21, 2024	05-21
Transcript : Diaceutics PLC, 2023 Earnings Call, May 21, 2024	05-21
Diaceutics PLC Reports Earnings Results for the Full Year Ended December 31, 2023	05-21	CI
EARNINGS AND TRADING: Michelmersh continues with positive order intake	05-16	AN
Diaceutics Bags Two Enterprise-wide Engagements with Large Pharmaceutical Companies	05-16	MT
Diaceutics plc Announces Two New Enterprise-Wide Engagements	05-16	CI
Roadside shares suspended; Adnams looks for funds	04-02	AN
Diaceutics upgrades diagnositc commercialisation platform, DXRX	03-21	AN
Diaceutics PLC Launches Significant Upgrade to Its DXRX Platform	03-21	CI
Sondrel wins USD23 million contract	02-27	AN
Diaceutics Expands Lab Network, Data Coverage in Europe	02-27	MT
Diaceutics announces new marketing partnership with KPMG	02-14	AN
Diaceutics maintains "momentum" for year ahead on revenue rise in 2023	01-30	AN
Diaceutics revenue grows but loss widens, CEO Keeling to step down	26/09/23	AN
Diaceutics Announces Executive Changes	26/09/23	CI
Diaceutics CEO to Resign; Chief Innovation Officer Named Successor	26/09/23	MT
Earnings Flash (DXRX.L) DIACEUTICS Posts H1 Revenue GBP9.9M	26/09/23	MT
Diaceutics PLC Reports Earnings Results for the Half Year Ended June 30, 2023	26/09/23	CI
Diaceutics PLC Announces Executive Changes, Effective 1 October 2023	21/09/23	CI
Diaceutics launches daily alerts for DXRX platform	29/08/23	AN
Diaceutics plc Launches Daily Alerts for Dxrx Platform	29/08/23	CI
Diaceutics interim revenue jumps as order book grows to GBP24 million	25/07/23	AN
Diaceutics PLC Announces Revenue Results for the Six Months Ended 30 June 2023	25/07/23	CI
Diaceutics shares surge on contract win with top US firm	05/06/23	AN

Chart Diaceutics PLC

Duration

Period

More charts

Company Profile

Diaceutics PLC is a United Kingdom-based company, which is a provider of technology and solutions. The Company provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. The Company operates through three segments: Insight Solutions (Data), Engagement Solutions (Tech enabled services), and Advisory Services (Professional services). The Companyâs DXRX - The Diagnostics Network is a diagnostic commercialization platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories. It provides unrivalled access to multiple pipelines of real-world diagnostic testing data from a global network of laboratories. Its Tech Enabled Services offers clinical testing labs to provide enablement and educational services in novel biomarkers.

Sector

Business Support Services

Calendar

12/06/2024 - Capital Markets Day

More about the company

Income Statement Evolution

More financial data

Ratings for Diaceutics PLC

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.275 GBP

Average target price

1.666 GBP

Spread / Average Target

+30.67%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Data Processing Services

	1st Jan change	Capi.
DIACEUTICS PLC	+46.21%	137M
VERRA MOBILITY CORPORATION	+18.54%	4.55B
WNS (HOLDINGS) LIMITED	-17.69%	2.36B
COMPUTER AGE MANAGEMENT SERVICES LIMITED	+35.36%	2.06B
KEHUA DATA CO., LTD.	-7.59%	1.63B
BLS INTERNATIONAL SERVICES LIMITED	+2.86%	1.59B
SDIC INTELLIGENCE XIAMEN INFORMATION CO., LTD.	-18.98%	1.54B
JMDC INC.	-33.24%	1.17B
SHANGHAI @HUB CO.,LTD.	-8.07%	1.16B
FUJIAN START GROUP CO.LTD	-7.40%	1.02B

Data Processing Services

Diaceutics PLC

Equities

DXRX

GB00BJQTGV64

Business Support Services

Diaceutics PLC Provides Earnings Guidance for the Year Ended 31 December 2019

EPS Revisions